Back to Researchers
Profile photo Richard Meijer

Richard Meijer

Associate Professor - medical

Strategic program(s):

Cancer

Biography

Current positions

2018-present    Associate Professor Oncological Urology, UMC Utrecht

2018-present    Head Department Oncological Urology, UMC Utrecht Cancer Center 

2012-present    Oncological Urologist, University Medical Center Utrecht (UMCU), The Netherlands

2016-present    Deputy Chief of the Specialist Medical Training Urology UMC Utrecht

2016-present    Chairman of the Oncological Urology Tumour Group, UMCU Cancer Center

2016-present    Member of the Oncology Committee, UMCU Cancer Center

2016-present    Associate member of ERUS (EAU Robotic Urology Section)

2015-present    Member of the Dutch Uro-Oncological Society (DUOS)

2015-present    Member Workgroup Oncological Urology (WOU) of the Dutch Urological Association                (Dutch: NVU)

2015                 SKMS workgroup Laparoscopy and Robotic Surgery

2014-present    Associate member of ESOU (EAU Section of Oncological Urology)

2011-present    Editorial Board Dutch Journal of Urology (Dutch: Tijdschrift voor Urologie)

Prior positions

2010-2012       Fellowship Oncological Urology, NKI-AVL, Amsterdam, The Netherlands; Supervisor Prof. Dr. S. Horenblas

Oct 2009          Fellowship Laparoscopy, Universitäts Klinikum Leipzig, Germany; Supervisor Prof. Dr. J.U. Stolzenburg

2008-2009       Resident in Urology, University Medical Center Utrecht, The Netherlands; Supervisor Prof. Dr. J.L.H.R. Bosch

2006-2007       Resident in Urology, JBZ, ’s-Hertogenbosch; Supervisor Dr. H.P. Beerlage

2004-2005       Resident in Surgery, Diakonessenhuis Utrecht, Supervisor Dr. G.J. Clevers

 

Current research projects

Research support (institutional)

  • Janssen (Research-grant) (2017-2022)
  • Roche (Research-grant) (2017-2021)
  • Astellas (Research-grant) (2021-2022)
  • Merck (Educational-grant) (2022)
  • Janssen/Astellas/AstraZeneca/MSD/BMS/Roche/Merck (ProBCI support) (2018---)

Company Advisory Boards (institutional):

  • Merck
  • MSD
  • Janssen
  • Bristol-Myers Squibb Company

2023 Framingham selection Urothelial Cancer Issues (Bristol-Myers Squibb Company; institutional)

Strategic program(s):

Cancer

Contact

rmeijer6@umcutrecht.nl
Pure profile

Research groups

Translational oncology

Research aim

To develop, test, and implement novel therapeutic and diagnostic strategies to combat cancer by integrating fundamental and clinical research.
Go to group

Uro-oncology research group

Research aim

Pioneering precise diagnostics in urologic oncology research, employing cutting-edge imaging modalities and genetic profiling for early detection and personalized treatment strategies, revolutionizing patient care and outcomes.
Go to group

Recent publications

All publications
Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort Anke Richters, Debbie G.J. Robbrecht, Richard P. Meijer, Antoine G. van der Heijden, Lambertus A.L.M. Kiemeney, Joan van den Bosch, Britt B.M. Suelmann, Berna C. Özdemir, Niven Mehra, Katja K.H. Aben,
European Urology Open Science, 2024, vol. 59, p.50-54
Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma Thomas van Doeveren, Sebastiaan Remmers, Vera Atema, Roderick C.N. van den Bergh, Egbert R. Boevé, Erik B. Cornel, Antoine G. van der Heijden, Kees Hendricksen, Evelyne C.C. Cauberg, Rens A.L. Jacobs, Bin K. Kroon, Annemarie M. Leliveld, Richard P. Meijer, Bob Merks, Jorg R. Oddens, Luc Roelofs, Diederik M. Somford, Peter de Vries, Bart Wijsman, Willemijn A.K.M. Windt, Peter J. Zwaan, Pim J. van Leeuwen, Joost L. Boormans, Katja K.H. Aben
European Urology Open Science, 2024, vol. 60, p.15-23
Perspectives and Concerns on Late Effects Regarding Sexuality among Adolescents and Young Adults Treated for Testicular Germ Cell Tumor Stefan T Kuiper, Daniëlle Zweers, Britt B M Suelmann, Richard P Meijer, Sigrid C J M Vervoort
Cancers, 2024, vol. 16
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer J Alfred Witjes, Harman Max Bruins, Albert Carrión, Richard Cathomas, Eva Compérat, Jason A Efstathiou, Rainer Fietkau, Georgios Gakis, Anja Lorch, Alberto Martini, Laura S Mertens, Richard P Meijer, Matthew I Milowsky, Yann Neuzillet, Valeria Panebiaco, John Redlef, Michael Rink, Mathieu Rouanne, George N Thalmann, Sæbjørn Sæbjørnsen, Erik Veskimäe, Paramananthan Mariappan, Antoine G van der Heijden
European Urology, 2024, vol. 85
Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine Amy de Haar-Holleman, Lisa M C van Hoogstraten, Maarten C C M Hulshof, Metin Tascilar, Katharina Brück, J Alfred Witjes, Richard P Meijer, Lambertus A Kiemeney, Katja K H Aben,
Radiotherapy & Oncology, 2023, vol. 183, p.109584
Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer Anke Richters, Noor van Ginkel, Richard P Meijer, Maurits Wondergem, Ivo Schoots, André N Vis, Lambertus A L M Kiemeney, Bas W G van Rhijn, J Alfred Witjes, Katja K H Aben, Laura S Mertens
BJU International, 2023, vol. 132, p.420-427

External positions

Panelmember EAU Muscle-invasive and Metastatic Bladder Cancer (MIBC) Guidelines Panel - Aandachtsgebied blaaskanker - European Association of Urology

Panelmember EAU Guideline Primary Urethral Carcinoma - Europese richtlijn commissie - European Association of Urology

Stuurgroep ProBCI - Blaaskanker expertise - Stichting Prospectieve Blaaskanker Infrastructuur (ProBCI)

Plaatsvervangend opleider Urologie UMCU - Plaatsvervangend opleider Urologie UMCU - UMCU

Associate member of ERUS (EAU Robotic Urology Section) - Associate member of ERUS (EAU Robotic Urology Section) - European Association of Urology

Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale - Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale NFU accreditatie (ECZA) - UMCU

Lid van Dutch Uro-Oncological Society (DUOS) - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de DUOS - Dutch Uro-Oncological Society (DUOS)

Lid Werkgroep Oncologische Urologie (WOU) van de NVU - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de Werkgroep Oncologische Urologie (WO - Nederlandse Vereniging voor Urologie

Associate member of ESOU (EAU Section of Oncological Urology) - Associate member of ESOU (EAU Section of Oncological Urology) - European Association of Urology